Navigation Links
Omeros Announces $16.2 Million Registered Direct Offering of Common Stock
Date:5/9/2013

SEATTLE, May 9, 2013 /PRNewswire/ -- Omeros Corporation (NASDAQ: OMER) today announced that it has agreed to sell 3,903,004 shares of its common stock at a price of $4.14 per share, a two percent premium over the closing price on May 8, 2013, for gross proceeds of $16.2 million. The shares were offered and are expected to be sold to RA Capital Management and other investors in a registered direct offering conducted without an underwriter or placement agent. The net proceeds from the offering, after deducting estimated offering expenses, will be approximately $16.1 million. The offering is expected to close on or about May 14, 2013.

Omeros intends to use the net proceeds of the offering for general corporate purposes, including expenses related to the potential commercialization of OMS302 for intraocular lens replacement, as well as for research and development expenses, such as funding planned clinical trials for its OMS103HP, PDE10, MASP-2 and PDE7 programs. The net proceeds may also be used to fund pre-clinical studies, capital expenditures, working capital and to otherwise advance Omeros' potential products towards commercialization.

The securities were offered by means of a prospectus supplement dated May 9, 2013 and accompanying prospectus dated October 18, 2010, forming a part of the Company's effective shelf registration statement (File No. 333-169856). Omeros has filed a registration statement (including a prospectus) with the Securities and Exchange Commission, or SEC, for the offering to which this communication relates. Before you invest, you should read the prospectus in that registration statement and other documents Omeros has filed with the SEC for more complete information about Omeros and this offering. You may get these documents for free by visiting EDGAR on the SEC web site at www.sec.gov. A
'/>"/>

SOURCE Omeros Corporation
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Omeros Ophthalmology Product OMS302 Granted Eligibility for European Centralized Review
2. Omeros to Present Additional OMS302 Clinical Data at the Annual ASCRS and ASOA Symposium and Congress
3. Omeros Files Orphan Drug Application for Treatment of Atypical Hemolytic Uremic Syndrome with OMS721
4. Omeros Announces that GPR17 Antagonists Improve Function in Model of Multiple Sclerosis
5. Omeros Announces Positive OMS721 Data in Model of Thrombotic Microangiopathy
6. Omeros to Present at the 2013 Future Leaders in the Biotech Industry Conference
7. Omeros Announces Toxicology Data that Support Advancing MASP-2 Inhibitor into Clinical Trials
8. Omeros Announces Successful Completion of PDE10 Phase 1 Multiple Ascending Dose Trial
9. Omeros Elucidates Mechanism of its PDE7 Inhibitors in Addiction
10. Omeros to Present at the Cowen and Company 33rd Annual Health Care Conference
11. Omeros Announces Toxicology Study Data from MASP-2 Inhibitor
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/18/2014)... LOUISVILLE, Ky. , Sept. 18, 2014 ... of innovative laboratory technologies and products to ... settings, announced today an amended distributorship agreement ... Sysmex reagents, controls and instruments, including the ... , Sysmex XP-300™, XT-Series and XN-Series Automated ...
(Date:9/18/2014)... , Sept. 18, 2014 Research ... "Micro Market Monitor : Global Chiral Separation Columns Market" ... separation chromatography is a technique involving two enantiomers of ... phase consisting of a single enantiomer, thus possessing different ... oligosaccharides such as cellulose. The chiral separation ...
(Date:9/18/2014)... Sept. 18, 2014 Research and Markets ... PTCA Balloon Market Investment Report, 2014-2016" report to ... indispensable medical device in percutaneous coronary intervention (PCI), serves ... also as a device for pre-/post-stent dilatations. Therefore, the ... that of PCI. As national economy develops ...
Breaking Medicine Technology:LABSCO Renews Sysmex Distributorship Agreement 2LABSCO Renews Sysmex Distributorship Agreement 3Micro Market Monitor: Global Chiral Separation Columns Market 2China PTCA Balloon Market Investment Report, 2014-2016 2China PTCA Balloon Market Investment Report, 2014-2016 3
... Mich., Nov. 15, 2010 Adeona Pharmaceuticals, Inc. ... for serious central nervous system diseases, announced today its third ... operational achievements. Adeona,s Recent Clinical and Operational ... Alzheimer,s Disease All 60 patients ...
... to demo a new tool for personalized preventive medicine ... applying for FDA clearance, this comprehensive risk assessment tool, ... the thickness of the C-IMT and detects plaque in ... for screening and unlike anything else out there. ...
Cached Medicine Technology:Adeona Announces Third Quarter 2010 Financial Results and Achievements 2Adeona Announces Third Quarter 2010 Financial Results and Achievements 3Adeona Announces Third Quarter 2010 Financial Results and Achievements 4Adeona Announces Third Quarter 2010 Financial Results and Achievements 5Panasonic Unveils CardioHealth® Station - First Comprehensive Screening Solution to Detect Heart Disease in Asymptomatic Population 2
(Date:9/18/2014)... September 19, 2014 In ... Neighborhood Mission (Misión Barrio Adentro), which it ... healthcare system (see Section 6.1.3.). In 2009, ... an Autonomous Service of Pharmaceutical Elaborations (Servicio ... which provides medicines at a cheaper rate ...
(Date:9/18/2014)... (PRWEB) September 18, 2014 Thousands of ... be recognizing their shared fundraising impact on 127 member ... 25. , The first-ever Dance Marathon Day will officially ... million projected to be raised by college and high ... Hospital. Donations generated through Dance Marathon campus programs help ...
(Date:9/18/2014)... (PRWEB) September 18, 2014 Ben Quirk, ... Alex Ormond, Jr. Leadership Award by the Savannah Science ... healthcare and wellness throughout the nation and especially in ... this award,” said Ben. “The Savannah Science Seminar is ... years and multiple generations have gone through the program,” ...
(Date:9/18/2014)... don,t worry, it,s a good thing! As scientists have ... bad. Many active enzymes and bacteria are merely benign, ... important part of our digestive system or can help ... an opportunistic yeast pathogen and model organism for research, ... ecosystem. However, when our immune system is stressed on ...
(Date:9/18/2014)... Non-governmental stakeholders will convene a one-day conference at the ... Washington University on September 25, 2014 to discuss the ... GHSA implementation. The purpose of this event is to ... the next five years, including action plans to curtail ... launch of the GHSA, international organizations and more than ...
Breaking Medicine News(10 mins):Health News:Venezuela Pharmaceutical Market worth $22.2 billion with 12% CAGR by 2020 Says a New Report Available at MarketOptimizer.org 2Health News:Venezuela Pharmaceutical Market worth $22.2 billion with 12% CAGR by 2020 Says a New Report Available at MarketOptimizer.org 3Health News:Venezuela Pharmaceutical Market worth $22.2 billion with 12% CAGR by 2020 Says a New Report Available at MarketOptimizer.org 4Health News:250 Campuses Usher in School Year of Saving Kids’ Lives During First-Ever “Dance Marathon Day” on Sept. 25 2Health News:Quirk Awarded the Alex Ormond, Jr. Leadership Award by the Savannah Science Seminar 2Health News:Everything in moderation: Micro-8 to study regulating pathogens in space 2Health News:Everything in moderation: Micro-8 to study regulating pathogens in space 3Health News:Non-governmental stakeholders to discuss the Global Health Security Agenda 2
... HealthDay Reporter , MONDAY, Sept. 20 (HealthDay News) -- ... be traced to a unexpected cause -- a certain strain ... research shows that youngsters who were infected by adenovirus 36, ... an average of 50 pounds heavier than children who hadn,t ...
... of Law at Arizona State University has been named ... Network, which launches today to provide legal and policy ... such as food safety, health reform and emergency preparedness. ... (PHLPP) received a $1.325 million grant from the Robert ...
... prostate tumors, promotes the growth of a different type of ... on September 20 in the Journal of Experimental Medicine ... colleagues find that TAL1, a protein abundantly expressed in approximately ... drives expression of NKX3.1. Eliminating NKX3.1 halted the growth ...
... FASEB MARC (Minority Access to Research Careers) Program ... Integrative Physiology of Exercise (IPE) Meeting in Miami, Florida ... meant to promote the entry of underrepresented minority students, ... science community and to encourage the participation of young ...
... Reporter , SUNDAY, Sept. 19 (HealthDay News) -- For asthma ... the addition of Spiriva -- a medication already approved for ... finds. However, the study authors and an outside expert ... clinical trials are needed. Tiotropium bromide (Spiriva)) belongs to ...
... of cancer researchers has identified four chromosome locations with ... risk of developing ovarian cancer. The findings appear in ... a Mayo Clinic researcher. Researchers say that while ... the specific chromosomal regions involved in susceptibility, the discoveries ...
Cached Medicine News:Health News:Childhood Obesity Might Be Linked to Strain of Cold Virus 2Health News:Childhood Obesity Might Be Linked to Strain of Cold Virus 3Health News:11-state regional Public Health Law Network office to be established at ASU College of Law 2Health News:11-state regional Public Health Law Network office to be established at ASU College of Law 3Health News:Early Trial Suggests COPD Drug Might Help Some Asthmatics 2Health News:Early Trial Suggests COPD Drug Might Help Some Asthmatics 3
... and international engineering and design specifications, ... Plating System* provides seamless integration with ... for open reduction internal fixational procedures ... works well beyond the standard, providing ...
... represents one of the most technically demanding ... Plating System offers the highly specialized surgeon ... fractures of the pelvis and acetabulum. ... a premiere pelvic surgeon, is the designer ...
... Conforming to U.S. and international engineering ... TC-100 Screw and Plating System* provides ... ease of use for open reduction ... the TC-100 system works well beyond ...
Comprehensive range of integrated implants and instruments including - Basic, Small, Mini, Pelvic and Foot Sets....
Medicine Products: